Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Accepts Indian Inspectors To Check Quality Of Bulk Drugs

This article was originally published in PharmAsia News

Executive Summary

China and India are launching a cooperative drug inspection effort that kicks off with India's Ministry of Health sending a team to China to inspect bulk drugs. India relies on China-produced bulk drugs for much of its drug production, but the Drug Controller General of India recently questioned the quality of those supplies. China is the source of 70 percent of bulk drugs imported by India. An industry official suggested the emphasis has been too much on the cheaper price of imported drugs and not enough on their quality. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072687

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel